INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

308 studies · page 8 of 13

2012 / Randomized controlled trial

Omega-3 fatty acids did not prevent cognitive decline in coronary heart disease patients.

In a randomized, double-blind, placebo-controlled trial, 2,911 coronary patients aged 60 to 80 years received margarines delivering 400 mg/day EPA-DHA, 2 g/day ALA, both, or placebo for 40 months. Changes in Mini-Mental State Examination scores did not differ between EPA-DHA and placebo (-0.65 vs -0.69 points, P = .44) or ALA and placebo (-0.60 vs -0.74 points, P = .12). Risk of cognitive decline was 1.03 (95% CI: 0.84-1.26) for EPA-DHA and 0.90 (95% CI: 0.74-1.10) for ALA.

Geleijnse JM, Giltay EJ, Kromhout D Alzheimers Dement, 2012. PMID 21967845

2012 / Randomized crossover trial

Tart cherry juice concentrate increased urinary melatonin and improved sleep duration and efficiency

In a randomized, double-blind, placebo-controlled crossover study, 20 healthy adults consumed tart cherry juice concentrate or placebo for seven days. Tart cherry juice significantly increased total urinary melatonin content compared to baseline and placebo (P < 0.05). Supplementation also led to significant gains in sleep duration, time spent in bed, and overall sleep efficiency (P < 0.05), alongside a trend toward higher circadian amplitude.

Howatson G, Bell PG, Tallent J, et al. Eur J Nutr, 2012. PMID 22038497

2012 / Double-blind, placebo-controlled crossover study

Acute administration of 300 mg EGCG increased EEG activity, enhanced self-rated calmness, and reduced self-rated stress compared to placebo.

In a double-blind, placebo-controlled crossover trial, participants completed baseline assessments of cognitive and cardiovascular functioning, mood, and resting state EEG before and 120 minutes following 300 mg EGCG or matched placebo. EGCG administration was associated with a significant overall increase in alpha, beta, and theta activity, which was also reflected in overall EEG activity and was more dominant in midline frontal and central regions (specifically the frontal gyrus and medial frontal gyrus). Compared to placebo, EGCG treatment also increased self-rated calmness and reduced self-rated stress.

Scholey A, Downey LA, Ciorciari J, et al. Appetite, 2012. PMID 22127270

2012 / Controlled clinical trial

High-fat meals and lipid infusions reduced circulating brain-derived neurotrophic factor in healthy men.

In 18 healthy young men undergoing euglycemic hyperinsulinemic clamps, raising free fatty acids via intralipid and heparin infusion significantly decreased serum brain-derived neurotrophic factor by 43% and plasma levels by 35% at 360 minutes. Hyperinsulinemia alone exerted no effect on neurotrophic factor levels. In a second cohort of 20 men, consuming a high-fat meal significantly decreased plasma brain-derived neurotrophic factor by 27.8% after 360 minutes.

Karczewska-Kupczewska M, Kowalska I, Nikołajuk A, et al. Diabetes Care, 2012. PMID 22210566

2012 / Randomized controlled trial

A vegetarian diet improved some short-term mood scores in omnivores.

Thirty-nine omnivores were randomized to continue eating animal products daily, eat fish weekly without meat, or adopt a vegetarian diet. After a two-week period, participants eliminating flesh foods showed significant improvements in several mood measures. Mood scores remained unchanged for participants in the daily meat and fish-eating groups.

Beezhold BL, Johnston CS Nutr J, 2012. PMID 22333737

2012 / Randomized placebo-controlled trial

Concord grape juice improved memory interference and altered brain activation in older adults.

Older adults with mild cognitive impairment received Concord grape juice or a placebo drink for 16 weeks. Grape juice consumption decreased semantic interference during memory assessments. Functional neuroimaging also revealed heightened neural responses in both anterior and posterior areas of the right hemisphere among participants who received the grape juice treatment.

Krikorian R, Boespflug EL, Fleck DE, et al. J Agric Food Chem, 2012. PMID 22468945

2012 / Single-blind functional MRI study on 2 measurement days

High-fat yogurt intake was linked to decreased hypothalamic cerebral blood flow.

Eleven healthy men underwent functional MRI measurements before, 30, and 120 minutes after eating high- and low-fat yogurts across two test days. High-fat yogurt intake was followed by a pronounced decline in hypothalamic cerebral blood flow, which correlated positively with changes in insulin levels. Insular cortex activity increased after 120 minutes solely under the low-fat yogurt condition.

Frank S, Linder K, Kullmann S, et al. Am J Clin Nutr, 2012. PMID 22572644

2012 / Randomized controlled trial

Cognitive defusion resulted in higher odds of chocolate abstinence than cognitive restructuring among self-identified chocolate cravers.

One-hundred-and-ten self-identified chocolate cravers were randomized to a waiting list control, a 60-minute group intervention on cognitive restructuring (CR), or cognitive defusion (CD), and instructed to carry a bag of chocolates for seven days while trying to resist eating them. Overall, the odds of abstinence from chocolate were 3.26 times higher for participants in the CD condition than the CR condition. For individuals with high baseline cognitive distress, CD led to significantly more restraint from chocolate than both CR and control conditions. Additionally, CD led to greater self-reported improvements in eating behaviors and was rated significantly easier to use and apply than CR.

Moffitt R, Brinkworth G, Noakes M, et al. Psychol Health, 2012. PMID 22691136

2012 / Randomized, double-blind, mixed-design trial

In caffeine-withdrawn consumers, caffeine primarily drove cognitive and mood improvements, while taurine and glucose had mixed, limited effects.

In a double-blind trial, 48 caffeine-deprived habitual consumers received combinations of caffeine (0 or 200 mg), taurine (0 or 2000 mg), and glucose (0 or 50 g) across four separate days. Caffeine enhanced executive control and working memory, reduced simple and choice reaction time, decreased fatigue, and increased tension and vigor. Taurine increased choice reaction time, reduced reaction time in working memory tasks, and reversed caffeine's effects on vigor and withdrawal symptoms. Glucose alone slowed choice reaction time, but combined with caffeine enhanced object working memory, and with taurine enhanced orienting attention; no effects were seen for cortisol or heart rate.

Giles GE, Mahoney CR, Brunyé TT, et al. Pharmacol Biochem Behav, 2012. PMID 22819803

2012 / Randomized controlled trial

Supplementary water intake and hydration status correlated with cognitive performance in children.

A randomized trial evaluated supplementary water provision among 168 children aged 9 to 11 years in Sardinia during the school day. Approximately 84% began the day in mild dehydration. Dehydration levels were negatively correlated with auditory number span scores, indicating an advantage for short-term memory with water supplementation. Conversely, dehydration was positively correlated with performance on a verbal analogy task.

Fadda R, Rapinett G, Grathwohl D, et al. Appetite, 2012. PMID 22841529

2012 / Controlled trial

Sweet orange essential oil inhalation mitigated acute psychological anxiety during an experimental stressor.

Forty healthy male volunteers inhaled sweet orange essential oil (2.5, 5, or 10 drops), tea tree oil, or water before completing an anxiety-inducing color-word test. Groups receiving 2.5 and 10 drops of orange aroma maintained baseline levels of state-anxiety, subjective tension, and tranquility (p>0.05). However, physiological alterations during the stress test were not prevented in any treatment group.

Goes TC, Antunes FD, Alves PB, et al. J Altern Complement Med, 2012. PMID 22849536

2012 / Randomized controlled trial

Caffeine did not reduce daytime sleepiness but improved motor scores in Parkinson disease.

Sixty-one patients with Parkinson disease and daytime somnolence were randomized to caffeine (up to 200 mg twice daily) or placebo for six weeks. Intention-to-treat analysis showed a nonsignificant change in Epworth Sleepiness Scale score (-1.71 points; 95% CI -3.57, 0.13). However, caffeine lowered the overall score on the Unified Parkinson's Disease Rating Scale (-4.69 points; 95% CI -7.7, -1.6) and its objective motor rating (-3.15 points; 95% CI -5.50, -0.83).

Postuma RB, Lang AE, Munhoz RP, et al. Neurology, 2012. PMID 22855866

2012 / Counterbalanced crossover trial

Viewing green video footage during simulated cycling reduced total mood disturbance and perceived exertion compared to gray or red filters.

Fourteen participants completed three moderate-intensity 5-minute cycling tasks while viewing simulated rural cycling footage that was unedited (green), achromatic (gray), or red-filtered in random counterbalanced order. Total mood disturbance and ratings of perceived exertion were lower during the green condition compared to the gray and red conditions. Anger was higher after the red condition compared to the others, while feelings of tension, depression, fatigue, vigor, and confusion did not differ among conditions.

Akers A, Barton J, Cossey R, et al. Environ Sci Technol, 2012. PMID 22857379

2012 / Randomized, parallel-group, double-blind, placebo-controlled trial

Long-term use of standardized Ginkgo biloba extract did not reduce the risk of progressing to Alzheimer's disease in elderly adults with memory complaints.

In the GuidAge trial, 2,854 adults aged 70 years or older with memory complaints were randomly allocated to receive 120 mg standardized Ginkgo biloba extract (EGb761) twice daily or placebo for 5 years. By 5 years, probable Alzheimer's disease was diagnosed in 61 participants in the ginkgo group (1.2 cases per 100 person-years) versus 73 in the placebo group (1.4 cases per 100 person-years; HR 0.84, 95% CI 0.60-1.18; p=0.306). Incidence of adverse events, all-cause deaths (76 vs 82; p=0.68), stroke (65 vs 60; RR 1.12, 95% CI 0.77-1.63; p=0.57), and other hemorrhagic or cardiovascular events did not differ significantly between groups.

Vellas B, Coley N, Ousset PJ, et al. Lancet Neurol, 2012. PMID 22959217

2012 / Controlled clinical trial

A low dose of lipidated curcumin altered several blood and saliva markers of wellness in healthy middle-aged adults.

A controlled study evaluated the effects of 80 mg/day of lipidated curcumin versus placebo for 4 weeks in healthy adults aged 40-60 years (N = 19 per group). Curcumin, but not placebo, led to statistically significant decreases in plasma triglycerides, salivary amylase, plasma beta amyloid protein, plasma sICAM, and plasma alanine amino transferase. It also led to statistically significant increases in salivary radical scavenging capacity, plasma catalase activities, plasma myeloperoxidase (without increased C-reactive protein), and plasma nitric oxide.

DiSilvestro RA, Joseph E, Zhao S, et al. Nutr J, 2012. PMID 23013352

2012 / Randomized controlled trial

A single slow breathing session improved heart rate variability and reduced anxiety in musicians with high baseline anxiety.

A total of 46 trained musicians were randomly allocated to slow breathing with or without biofeedback or a no-treatment control group to test effects on music performance anxiety. Slow breathing groups (n=30) showed significantly greater improvements in high frequency (effect size: η²=0.122) and LF/HF ratio (η²=0.116) measures of HRV compared to controls (n=15), with no extra benefit from biofeedback. While there was no overall reduction in self-reported anxiety across the full intervention group, participants with high baseline anxiety receiving the intervention (n=15) showed greater reductions in state anxiety compared to controls (n=7, r=0.379).

Wells R, Outhred T, Heathers JA, et al. PLoS One, 2012. PMID 23056361

2012 / Randomized, double-blind, placebo-controlled trial

In a 24-week randomized trial, oral curcumin showed no clinical or biomarker efficacy in mild-to-moderate Alzheimer's disease.

Thirty-six individuals with mild-to-moderate Alzheimer's disease were randomized to receive placebo, 2 g/day, or 4 g/day of oral Curcumin C3 Complex for 24 weeks. Curcumin was generally well-tolerated, though 3 of 24 participants in the curcumin group withdrew due to gastrointestinal symptoms. Curcumin was linked to clinically insignificant lowered hematocrit and increased glucose levels. No differences between treatment groups were observed in clinical cognitive outcomes or biomarker efficacy measures, with low levels of native curcumin measured in plasma (7.32 ng/mL).

Ringman JM, Frautschy SA, Teng E, et al. Alzheimers Res Ther, 2012. PMID 23107780

2012 / Post hoc analysis of a randomized double-blind placebo-controlled trial

Calcium and vitamin D3 supplementation did not reduce the risk of incident dementia or mild cognitive impairment in elderly women.

A post hoc analysis of the WHI trial evaluated 4,143 women aged 65 and older randomized to 1,000 mg of calcium carbonate plus 400 IU of vitamin D3 (n = 2,034) or placebo (n = 2,109). Over a mean follow-up of 7.8 years, incident dementia occurred in 39 treatment participants and 37 placebo participants (HR = 1.11, 95% CI = 0.71-1.74, P = .64). Incident MCI was diagnosed in 98 treatment and 108 placebo participants (HR = 0.95, 95% CI = 0.72-1.25, P = .72). There were no significant differences in incident dementia, MCI, or global and domain-specific cognitive function between groups.

Rossom RC, Espeland MA, Manson JE, et al. J Am Geriatr Soc, 2012. PMID 23176129

2012 / Interventional study

Prolonged 45-day head-down bed rest impaired executive functioning, decreased positive affect, and weakened galvanic skin response in healthy young men.

An emotional flanker task and self-report inventories were used to evaluate the effect of 45 days of -6° head-down bed rest (HDBR) in 16 healthy young men across six time points before, during, and after bed rest. Participants' reaction times on the flanker task increased significantly compared to baseline. Additionally, their galvanic skin response weakened and degrees of positive affect declined during the bed rest period. It remains to be determined whether these changes result from a lack of aerobic physical activity and/or HDBR itself.

Liu Q, Zhou R, Chen S, et al. PLoS One, 2012. PMID 23284916

2012 / Double-blind randomized clinical trial

Magnesium supplementation improved subjective sleep measures and altered serum renin, melatonin, and cortisol in elderly subjects.

In a double-blind randomized clinical trial, 46 elderly subjects received 500 mg magnesium or placebo daily for 8 weeks. Compared with placebo, magnesium supplementation brought about statistically significant increases in sleep time (P = 0.002), sleep efficiency (P = 0.03), serum renin (P < 0.001), and melatonin (P = 0.007). It also significantly decreased Insomnia Severity Index scores (P = 0.006), sleep onset latency (P = 0.02), and serum cortisol concentrations (P = 0.008), although total sleep time did not show a significant difference (P = 0.37).

Abbasi B, Kimiagar M, Sadeghniiat K, et al. J Res Med Sci, 2012. PMID 23853635

2012 / Experimental exposure study

Cognitive performance was significantly related to absorbed plasma 1,8-cineole concentration after exposure to rosemary essential oil aroma.

Twenty healthy volunteers completed serial subtraction and visual information processing tasks in a cubicle diffused with rosemary aroma, alongside mood assessments and venous blood sampling. Cognitive task performance was significantly related to the concentration of absorbed 1,8-cineole, with higher concentrations associated with improved speed and accuracy. Relationships with mood were less pronounced, though a significant negative correlation was observed between change in contentment and plasma 1,8-cineole levels.

Moss M, Oliver L Ther Adv Psychopharmacol, 2012. PMID 23983963

2011 / Crossover repeated measures study

Dehydration increased fronto-parietal brain activation during an executive function task in adolescents

In a crossover repeated-measures study of ten healthy adolescents, thermal exercise induced greater perspiration-related weight loss than a control condition (P < 0.0001). Lateral ventricle enlargement correlated with body mass reduction (r = 0.77, P = 0.01). Dehydration produced a significantly stronger fronto-parietal blood-oxygen-level-dependent signal during an executive task compared with control, while cognitive performance and resting cerebral perfusion remained unchanged.

Kempton MJ, Ettinger U, Foster R, et al. Hum Brain Mapp, 2011. PMID 20336685

2011 / Intervention study

A high-nitrate diet increased regional cerebral perfusion in frontal lobe white matter in older adults.

Older adults (mean age 74.7±6.9 years) were administered a high versus low nitrate diet to determine effects on cerebral blood flow. Cerebral perfusion was measured using arterial spin labeling magnetic resonance imaging. The high-nitrate diet did not alter global cerebral perfusion, but did increase regional cerebral perfusion in frontal lobe white matter, specifically between the dorsolateral prefrontal cortex and anterior cingulate cortex.

Presley TD, Morgan AR, Bechtold E, et al. Nitric Oxide, 2011. PMID 20951824

2011 / Randomized controlled trial

Probiotic formulation reduced psychological distress and urinary free cortisol in healthy adults

A randomized, double-blind, placebo-controlled trial tested a daily probiotic formulation of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 for 30 days in healthy volunteers. Supplementation significantly lowered psychological distress on the HSCL-90 global severity index (p < 0.05), depression (p < 0.05), and anger-hostility (p < 0.05). Probiotic intake also reduced 24-hour urinary free cortisol levels (p < 0.05).

Messaoudi M, Lalonde R, Violle N, et al. Br J Nutr, 2011. PMID 20974015